Arrowhead Pharmaceuticals...

NASDAQ: ARWR · Real-Time Price · USD
20.50
1.72 (9.16%)
At close: Aug 15, 2025, 3:59 PM
20.90
1.93%
After-hours: Aug 15, 2025, 07:44 PM EDT

Arrowhead Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is October - September.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Sep 30, 2024 Sep 30, 2023 Sep 30, 2022 Sep 30, 2021
Net Income
-609.69M -209.28M -176.49M -140.85M
Depreciation & Amortization
18.59M 12.49M 10.42M 8.27M
Stock-Based Compensation
73.97M 78.13M 120.89M 76.67M
Other Working Capital
30.63M -85.95M -100.55M 224.49M
Other Non-Cash Items
29.19M 16.31M 7.34M 266K
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
25.09M -51.55M -98.29M 226.87M
Operating Cash Flow
-462.85M -153.89M -136.13M 171.22M
Capital Expenditures
-141.47M -176.74M -52.78M -23.57M
Cash Acquisitions
n/a -80.58M -47.36M 141.68M
Purchase of Investments
-720.95M -246.14M -223.39M -240.7M
Sales Maturities Of Investments
442.34M 326.72M 270.75M 122.59M
Other Investing Acitivies
n/a 80.58M 47.36M -141.68M
Investing Cash Flow
-420.07M -96.16M -5.42M -141.68M
Debt Repayment
392M 250M n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
49.26M n/a 60M n/a
Financial Cash Flow
870.52M 253.05M 65.19M 11.3M
Net Cash Flow
-8.21M 2.89M -76.43M 40.85M
Free Cash Flow
-604.32M -330.63M -188.91M 147.66M